1. Field of the Invention
This invention relates generally to a multiple antenna ablation apparatus, and more particularly to a multiple antenna ablation apparatus where the size of the antennas' electromagnetic energy delivery surfaces is sufficient to prevent the apparatus from impeding out.
2. Description of the Related Art
Current open procedures for treatment of tumors are extremely disruptive and cause a great deal of damage to healthy tissue. During the surgical procedure, the physician must exercise care in not cutting the tumor in a manner that creates seeding of the tumor, resulting in metastasis. In recent years, development of products has been directed with an emphasis on minimizing the traumatic nature of traditional surgical procedures.
There has been a relatively significant amount of activity in the area of hyperthermia as a tool for treatment of tumors. It is known that elevating the temperature of tumors is helpful in the treatment and management of cancerous tissues. The mechanisms of selective treatment are not completely understood. However, four cellular effects of hyperthermia on cancerous tissue have been proposed, (i) changes in cell or nuclear membrane permeability or fluidity, (ii) cytoplasmic lysomal disintegration, causing release of digestive enzymes, (iii) protein thermal damage affecting cell respiration and the synthesis of DNA or RNA and (iv) potential excitation of immunologic systems. Treatment methods for applying heat to tumors include the use of direct contact radio-frequency (RF) applicators, microwave radiation, inductively coupled RF fields, ultrasound, and a variety of simple thermal conduction techniques.
Among the problems associated with all of these procedures is the requirement that highly localized heat be produced at depths of several centimeters beneath the surface of the skin. RF applications may be used at depth during surgery. However, the extent of localization is generally poor, with the result that healthy tissue may be harmed.
With RF lesion making, a high frequency alternating current flows from the electrode into the tissue. Ionic agitation is produced in the region of tissue about the electrode tip as the ions attempt to follow the directional variations of the alternating current. This agitation results in frictional heating so that the tissue about the electrode, rather than the electrode itself, is the primary source of heat. Tissue heat generated is produced by the flow of current through the electrical resistance offered by the tissue. The greater this resistance, the greater the heat generated.
Lesion size ultimately is governed by tissue temperature. Some idea of tissue temperature can be obtained by monitoring the temperature at an electrode or probe tip, usually with a thermistor. RF lesion heat is generated within the tissue, the temperature monitored will be the resultant heating of the electrode by the lesion. RF lesion heat is generated within the tissue, the temperature monitored is the resultant heating of the probe by the lesion. A temperature gradient extends from the lesion to the probe tip, so that the probe tip is slightly cooler than the tissue immediately surrounding it, but substantially hotter than the periphery of the lesion because of the rapid attenuation of heating effect with distance.
Current spreads out radially from the electrode tip, so that current density is greatest next to the tip, and decreases progressively at distances from it. The frictional heat produced from ionic agitation is proportional to current, i.e., ionic density. Therefore, the heating effect is greatest next to the electrode and decreases with distance from it. One consequence of this is that lesions can inadvertently be made smaller than anticipated for a given electrode size if the RF current level is too high. There must be time for equilibrium heating of tissue to be reached, especially at the center of the desired lesion volume. If the current density is too high, the tissue temperature next to the electrode rapidly exceeds desired levels and carbonization and boiling occurs in a thin tissue shell surrounding the electrode tip.
A need exists for a multiple antenna ablation apparatus with antenna electromagnetic energy delivery surface areas that are sufficiently large enough to prevent the apparatus from impeding out. There is a further need for a multiple antenna ablation apparatus with a sufficient number of antennas, providing a large enough electromagnetic energy delivery surface to a selected tissue site, to achieve volumetric ablation without impeding out the apparatus.
Accordingly, it is an object of the invention to provide an ablation device which includes multiple antennas that are deployed from a trocar into a selected tissue site.
Another object of the invention is to provide a multiple antenna ablation apparatus with electromagnetic energy delivery surfaces that are large enough to prevent the apparatus from impeding out.
Yet another object of the invention is to provide a multiple antenna ablation apparatus with a sufficient number of antennas to provide a large enough electromagnetic energy delivery from the antennas to prevent the apparatus from impeding out.
Still a further object of the invention is to provide a multiple antenna RF ablation apparatus with antenna electromagnetic energy delivery surfaces sufficiently large to prevent the apparatus from impeding out.
These and other objectives are achieved in a multiple antenna ablation apparatus. The apparatus includes an electromagnetic energy source, a trocar including a distal end, and a hollow lumen extending along a longitudinal axis of the trocar, and a multiple antenna ablation device with three or more antennas. The antennas are positionable in the trocar. At a selected tissue site the antennas are deployed from the trocar lumen in a lateral direction relative to the longitudinal axis. Each of the deployed antennas has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric ablation between the deployed antennas, and (ii) the volumetric ablation is achieved without impeding out any of the deployed antennas when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the multiple antenna ablation device. At least one cable couples the multiple antenna ablation device to the electromagnetic energy source.
In another embodiment, a method for creating a volumetric ablation in a selected tissue mass provides a multiple antenna ablation apparatus including a trocar with a trocar lumen, a plurality of antennas deployable from the lumen, and an electromagnetic energy source coupled to the plurality of antennas. The trocar is inserted into the selected tissue mass. The plurality of antennas are positioned in the trocar lumen before and after introduction of the trocar through tissue. The plurality of antennas are advanced from the trocar lumen in a lateral direction relative to a longitudinal axis of the trocar into the selected tissue mass. 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the plurality of antennas without impeding out an antenna of the plurality of antennas. The volumetric ablation is created between the plurality of antennas. In various embodiments, the apparatus can include each of the antennas coupled to the electromagnetic energy source, only one antenna coupled to the electromagnetic energy source, or more than one antenna coupled to the electromagnetic energy source. The trocar has an outer diameter of no greater than 13 gauge, preferably no greater than 14 gauge, and still more preferably no more than 15 gauge.
The number of deployed antennas can be four, five, six or more. Some of the antennas can be deployed out of the distal end of the trocar, while other antennas may be deployed from ports formed in the trocar along its longitudinal axis. The antennas may be RF electrodes operating in a monopolar mode, bipolar mode, or switchable between the two.
At least one sensor, preferably a thermal sensor, can be positioned along an exterior surface of a deployed antenna. More than one antenna can include a sensor. An insulation layer may be positioned in a surrounding relationship around at least a portion of an exterior of the trocar. A distal end of the insulation at the distal end of the trocar can be removed. This creates an electromagnetic energy delivery surface at the trocar's distal end. The trocar then becomes at least partially an antenna.
The trocar lumen may be coupled to an infusion medium source and deliver an infusion medium to the selected tissue site. A cooling element can be coupled to at least one of the antennas. The cooling element can be a structure positioned in at least one of the antennas and include at least one channel configured to receive a cooling medium. The cooling medium can be recirculated through the channel.
FIG. 1(a) is a perspective view of the multiple antenna ablation apparatus of the present invention illustrating a trocar and three laterally deployed antennas. FIG. 1(b) is a cross-sectional view illustrating the electrode advancement member at least partially positioned in the introducer of
FIG. 6(a) is a perspective view of the multiple antenna ablation of the present invention illustrating two antennas which provide a retaining and gripping function.
FIG. 6(b) is a perspective view of the multiple antenna ablation of the present invention illustrating three secondary antennas which provide a retaining and gripping function.
FIG. 6(c) is a cross-sectional view of the apparatus of FIG. 6(b) taken along the lines 6(c)—6(c).
The present invention provides a multiple antenna ablation apparatus. The apparatus includes an electromagnetic energy source, a trocar including a distal end, and a hollow lumen extending along a longitudinal axis of the trocar, and a multiple antenna ablation device with three or more antennas. The antennas are initially positioned in the trocar lumen as the trocar is introduced through tissue. At a selected tissue site the antennas are deployable from the trocar lumen in a lateral direction relative to the longitudinal axis. Each of the deployed antennas has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric ablation between the deployed antennas, and (ii) create the volumetric ablation without impeding out any of the deployed antennas when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the multiple antenna ablation device. In other embodiments, 5 to 100 watts, 5 to 75 watts and 5 to 50 watts of electromagnetic energy is delivered to the deployed antennas from the electromagnetic energy source without impeding out the deployed antennas. At least one cable couples the multiple antenna ablation device to the electromagnetic energy source. For purposes of this specification the term “impeding out” means that a tissue area has become sufficiently desiccated or carbonized that the desiccated or carbonized tissue area has a resultant high electrical resistance that impairs the process of creating a coagulating lesion.
As shown in FIG. 1(a), multiple antenna ablation device 12 includes a trocar 14, and one or more antennas 16, which are typically electrodes. Antennas 16 can be positioned initially in a trocar lumen when trocar 14 is advanced through tissue and introduced through the trocar lumen after trocar is advanced through tissue. When trocar 14 reaches a selected tissue ablation site in a selected tissue mass, including but not limited to a solid lesion, antennas 16 are laterally deployed relative to the trocar's longitudinal axis from the trocar lumen into the selected tissue mass. Volumetric ablation proceeds from the interior of the selected tissue mass in a direction towards a periphery of the selected tissue mass.
Each antenna has a distal end 16′ which extends in a lateral direction relative to a longitudinal axis of trocar 14. Unless the distal ends 16′ have insulation, then their entire length of extension is an electromagnetic energy delivery surface which delivers electromagnetic energy to the selected tissue mass. The length and size of each electromagnetic energy delivery surface can be variable. Lengths of antennas 16 can be adjustable. Trocar 14 can be moved up and down, rotated about its longitudinal axis, and moved back and forth, in order to define, along with sensors, the periphery or boundary of the selected tissue mass, including but not limited to a tumor. This provides a variety of different geometries, not always symmetrical, that can be ablated. Volumetric ablation is defined as the creation of an ablation with a periphery formed between adjacent distal ends 16′. The volume of non-ablated tissue between adjacent distal ends 16′ is minimized. A variety of different geometric ablations are achieved including but not limited to spherical, semi-spherical, spheroid, triangular, semi-triangular, square, semi-square, rectangular, semi-rectangular, conical, semi-conical, quadrilateral, semi-quadrilateral, semi-quadrilateral, rhomboidal, semi-rhomboidal, trapezoidal, semi-trapezoidal, combinations of the preceding, geometries with non-planar sections or sides, free-form and the like.
In one embodiment, trocar 14 can have a sharpened distal end 14′ to assist introduction through tissue. Each antenna 16 has a distal end 16′ that can be constructed to be less structurally rigid than trocar 14. Distal end 16′ is the section of antenna 16 that is advanced from the lumen antenna 14 and into the selected tissue mass. Distal end is typically less structurally rigid that trocar 14. Structural rigidity is determined by, (i) choosing different materials for trocar 14 and distal end 16′ or some greater length of antenna 16, (ii) using the same material but having less of it for antenna 16 or distal end 16′, e.g., antenna 16 or distal end 16′ is not as thick as trocar 14, or (iii) including another material in trocar 14 or an antenna 16 to vary their structural rigidity. For purposes of this disclosure, structural rigidity is defined as the amount of deflection that an antenna has relative to its longitudinal axis. It will be appreciated that a given antenna will have different levels of rigidity depending on its length.
Antennas 16 can be made of a variety of conductive materials, both metallic and non-metallic. One suitable material is type 304 stainless steel of hypodermic quality. In some applications, all or a portion of secondary electrode 16 can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif.
Each of the antennas 16 can have different lengths. The lengths can be determined by the actual physical length of an antenna 16, the length of an antenna electromagnetic energy delivery surface, and the length of an antenna 16 that is not covered by an insulator. Suitable lengths include but are not limited to 17.5 cm, 25.0 cm. and 30.0 cm. The actual length of an antenna 16 depends on the location of the selected tissue mass to be ablated, its distance from the skin, its accessibility as well as whether or not the physician chooses a laparoscopic, percutaneous or other procedure.
An insulation sleeve 18 may be positioned around an exterior of trocar 14 and/or antennas 16. All or some of insulation sleeves 18 may be adjustably positioned so that the length of an antenna electromagnetic energy delivery surface can be varied. Each insulation sleeve 18 surrounding a trocar 14 can include one or more apertures. This permits the introduction of a antenna 16 through trocar 14 and insulation sleeve 18.
In one embodiment, insulation sleeve 18 comprises a polyamide material. A sensor 24 may be positioned on top of polyimide insulation sleeve 18. The polyamide insulation sleeve 18 is semi-rigid. Sensor 24 can lay down substantially along the entire length of polyamide insulation sleeve 18. Trocar 14 is made of a stainless-steel hypodermic tubing. Antennas 16 have distal ends 16′ that are made of NiTi hypodermic tubing. A handle is included with markings to show the length of lateral deployment of antennas 16 from trocar 14. Fluid infusion is delivered through a Luer port at a side of the handle. Type-T thermocouples are positioned at distal ends 16′.
An electromagnetic energy source 20 is connected to multiple antenna device 12 with one or more cables 22. Electromagnetic energy source 20 can be an RF source, microwave source, short wave source, laser source and the like. Multiple antenna device 12 can be comprised of antennas 16 that are RF electrodes, microwave antennas, as well as combinations thereof. Electromagnetic energy source 20 may be a combination RF/microwave box. Further a laser optical fiber, coupled to a laser source 20 can be introduced through one or both of trocar 14 or a antenna 16. Trocar 14 and/or a secondary electrode 16 can be an arm for the purposes of introducing the optical fiber.
Antennas 16 are electromagnetically coupled to electromagnetic energy source 20. The coupling can be direct from electromagnetic energy source 20 to each antenna 16, or indirect by using a coilet, sleeve and the like which couples one or more antennas 16 to electromagnetic energy source 20. Electromagnetic energy can be delivered from one antenna 16 to another.
One or more sensors 24 may be positioned on at least a portion of interior or exterior surfaces of trocar 14, antenna 16 or insulation sleeve 18. Preferably sensors 24 are positioned at trocar distal end 14′, antenna distal end 16′ and insulation sleeve distal end 18′. Sensors 24 permit accurate measurement of temperature at a tissue site in order to determine, (i) the extent of ablation, (ii) the amount of ablation, (iii) whether or not further ablation is needed and (iv) the boundary or periphery of the ablated mass. Further, sensors 24 prevent nontargeted tissue from being destroyed or ablated.
Sensors 24 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. Suitable thermal sensors 24 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. It will be appreciated that sensors 24 need not be thermal sensors.
Sensors 24 measure temperature and/or impedance to permit monitoring and a desired level of ablation to be achieved without destroying too much tissue. This reduces damage to tissue surrounding the targeted mass to be ablated. By monitoring the temperature at various points within the interior of the selected tissue mass, a determination of the selected tissue mass periphery can be made, as well as a determination of when ablation is complete. If at any time sensor 24 determines that a desired ablation temperature is exceeded, then an appropriate feedback signal is received at electromagnetic energy source 20 which then regulates the amount of electromagnetic energy delivered to antennas 16.
Thus the geometry of the ablated mass is selectable and controllable. Any number of different ablation geometries can be achieved. Creation of different ablation geometries is dependent on the length of electromagnetic energy ablation delivery surfaces, the number of antennas, the size of the electromagnetic delivery surfaces, the amount of power delivered to the antennas, and the duration of time for power delivery to the antennas.
Antenna distal ends 16′ can be laterally deployed relative to a longitudinal axis of trocar 14 out of an aperture 26 formed in trocar 14. Aperture 26 is at distal end 14′ or formed in a side of an exterior of antenna 14.
In one embodiment, a method for creating a volumetric ablation in a selected tissue mass provides multiple antenna ablation apparatus 12 including trocar 14 with a trocar lumen, a plurality of antennas 16 deployable from the lumen, and an electromagnetic energy source 20 coupled to the plurality of antennas. Trocar 14 is inserted into the selected tissue mass with the plurality of antennas positioned in the trocar 14 lumen. The plurality of antennas 16 are advanced from the trocar lumen in a lateral direction relative to a longitudinal axis of trocar 14 into the selected tissue mass. 10 to 50 watts, preferably 10 to 30, and still more preferably 15 to 20 watts of electromagnetic energy is delivered from electromagnetic energy source 20 to the plurality of antennas 16 without impeding out an antenna of the plurality of antennas. The volumetric ablation is created between the plurality of antennas 16.
There is wide variation in the amount of deflection of antenna 16. For example, antenna 16 can be deflected a few degrees from the longitudinal axis of trocar 14, or antennas 16 can be deflected in any number of geometric configurations, including but not limited to a “J” hook. Further, antennas 16 are capable of being introduced from trocar 14 a few millimeters from trocar 14, or a much larger distance. A cam 25 or other device can be positioned within trocar 14 to advance and retract antenna 16 in and out of trocar 14.
As illustrated in
In
In
Referring now to
Antennas 16 can serve the additional function of anchoring multiple antenna device 12 in a selected mass, as illustrated in FIGS. 6(a) and 6(b). In FIG. 6(a) one or both antennas 16 are used to anchor and position trocar 14. Further, one or both antennas 16 are also used to ablate tissue. In FIG. 6(b), three antennas are deployed and anchor trocar 14.
FIG. 6(c) illustrates the infusion capability of multiple antenna device 12. Three antennas 16 are positioned in a central lumen 14″ of trocar 14. One or more of the antennas 16 can also include a central lumen coupled to an infusion source. Central lumen 14″ is coupled to an infusion source and delivers a variety of infusion mediums to selected places both within and outside of the targeted ablation mass. Suitable infusion mediums include but are not limited to, therapeutic agents, conductivity enhancement mediums, contrast agents or dyes, and the like. An example of a therapeutic agent is a chemotherapeutic agent.
As shown in
In
A feedback control system 29 is connected to electromagnetic energy source 20, sensors 24 and antennas 16. Feedback control system 29 receives temperature or impedance data from sensors 24 and the amount of electromagnetic energy received by antennas 16 is modified from an initial setting of ablation energy output, ablation time, temperature, and current density (the “Four Parameters”). Feedback control system 29 can automatically change any of the Four Parameters. Feedback control system 29 can detect impedance or temperature and change any of the Four Parameters. Feedback control system 29 can include a multiplexer to multiplex different antennas, a temperature detection circuit that provides a control signal representative of temperature or impedance detected at one or more sensors 24. A microprocessor can be connected to the temperature control circuit.
The following discussion pertains particularly to the use of an RF energy source and RF electrodes. It will be appreciated that devices similar to those associated with RF multiple antenna device 12 can be utilized with laser optical fibers, microwave devices and the like.
Referring now to
A control signal is generated by controller 38 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at antennas 16.
In a similar manner, temperatures detected at sensors 24 provide feedback for determining the extent of ablation, and when a completed ablation has reached the physical location of sensors 24. The actual temperatures are measured at temperature measurement device 42 and the temperatures are displayed at user interface and display 36. A control signal is generated by controller 38 that is proportional to the difference between an actual measured temperature, and a desired temperature. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor 24. A multiplexer can be included to measure current, voltage and temperature, at the numerous sensors 24, and energy is delivered to antennas 16.
Controller 38 can be a digital or analog controller, or a computer with software. When controller 38 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus are a program memory and a data memory.
User interface and display 36 includes operator controls and a display. Controller 38 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
The output of current sensor 30 and voltage sensor 32 is used by controller 38 to maintain a selected power level at antennas 16. The amount of RF energy delivered controls the amount of power. A profile of power delivered can be incorporated in controller 38, and a preset amount of energy to be delivered can also be profiled.
Circuitry, software and feedback to controller 38 result in process control, and the maintenance of the selected power, and are used to change, (i) the selected power, including RF, microwave, laser and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery and (iv) infusion medium delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored at sensors 24.
Referring now to
Microprocessor 50 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 50 corresponds to different temperatures and impedances.
Calculated power and impedance values can be indicated on user interface and display 36. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared by microprocessor 50 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 36, and additionally, the delivery of RF energy can be 10 reduced, modified or interrupted. A control signal from microprocessor 50 can modify the power level supplied by electromagnetic energy source 20.
The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.
This application is a continuation-in-part of U.S. patent application Ser. No. 08/605,323, filed Feb. 14, 1996, now U.S. Pat. No. 5,728,143, which is a continuation-in-part of U.S. patent application Ser. No. 08/515,379, filed Aug. 15, 1995, now U.S. Pat. No. 5,683,384, which is a continuation-in-part of U.S. Pat. application Ser. No. 08/290,031, filed Aug. 12, 1994, now U.S. Pat. No. 5,536,267 which is a continuation-in-part of U.S. patent application Ser. No. 08/148,439, filed Nov. 8, 1993, now U.S. Pat. No. 5,458,597, each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3474777 | Figge et al. | Oct 1969 | A |
3834392 | Lampman et al. | Sep 1974 | A |
3858586 | Lessen | Jan 1975 | A |
3987795 | Morrison, Jr. | Oct 1976 | A |
3991770 | LeVeen | Nov 1976 | A |
4011872 | Komiya | Mar 1977 | A |
4016881 | Rioux et al. | Apr 1977 | A |
4016886 | Doss | Apr 1977 | A |
4026301 | Friedman et al. | May 1977 | A |
4033351 | Hetzel | Jul 1977 | A |
4043342 | Morrison, Jr. | Aug 1977 | A |
4074718 | Morrison, Jr. | Feb 1978 | A |
4080959 | Leveen | Mar 1978 | A |
4085756 | Weaver | Apr 1978 | A |
4095602 | Leveen | Jun 1978 | A |
4119102 | LeVeen | Oct 1978 | A |
4121592 | Whalley | Oct 1978 | A |
4140130 | Storm, III | Feb 1979 | A |
4154246 | LeVeen | May 1979 | A |
4230129 | LeVeen | Oct 1980 | A |
4237898 | Whalley | Dec 1980 | A |
4269174 | Adair | May 1981 | A |
4285346 | Armitage | Aug 1981 | A |
4289135 | Nordensrom et al. | Sep 1981 | A |
4290435 | Waggott | Sep 1981 | A |
4303636 | Gordon | Dec 1981 | A |
4331654 | Morris | May 1982 | A |
4337760 | Rubin | Jul 1982 | A |
4345588 | Widder et al. | Aug 1982 | A |
4346715 | Gammell | Aug 1982 | A |
4375220 | Matvias | Mar 1983 | A |
4409993 | Furihata | Oct 1983 | A |
4411266 | Cosman | Oct 1983 | A |
4418692 | Guay | Dec 1983 | A |
4461283 | Doi | Jul 1984 | A |
4506680 | Stokes | Mar 1985 | A |
4512762 | Spears | Apr 1985 | A |
4524770 | Orandi | Jun 1985 | A |
4532924 | Auth et al. | Aug 1985 | A |
4545368 | Rand et al. | Oct 1985 | A |
RE32057 | LeVeen | Dec 1985 | E |
RE32066 | Leveen | Jan 1986 | E |
4562838 | Walker | Jan 1986 | A |
4565200 | Cosman | Jan 1986 | A |
4574782 | Borrelli et al. | Mar 1986 | A |
4583556 | Hines et al. | Apr 1986 | A |
4586490 | Katz | May 1986 | A |
4601296 | Yerushalmi | Jul 1986 | A |
4648892 | Kittrell et al. | Mar 1987 | A |
4652257 | Chang | Mar 1987 | A |
4658819 | Harris et al. | Apr 1987 | A |
4660571 | Hess et al. | Apr 1987 | A |
4662359 | Gordon | May 1987 | A |
4676258 | Inokuchi et al. | Jun 1987 | A |
4690130 | Mirell | Sep 1987 | A |
4692139 | Stiles | Sep 1987 | A |
4709701 | Weber | Dec 1987 | A |
4753248 | Engler et al. | Jun 1988 | A |
4763671 | Goffinet | Aug 1988 | A |
4776086 | Kasevich et al. | Oct 1988 | A |
4800899 | Elliott | Jan 1989 | A |
4813429 | Eshel et al. | Mar 1989 | A |
4818542 | DeLuca et al. | Apr 1989 | A |
4823791 | D'Amelio et al. | Apr 1989 | A |
4823793 | Angulo et al. | Apr 1989 | A |
4825880 | Stauffer et al. | May 1989 | A |
4838265 | Cosman et al. | Jun 1989 | A |
4846196 | Wiksell et al. | Jul 1989 | A |
4860744 | Johnson et al. | Aug 1989 | A |
4862887 | Weber et al. | Sep 1989 | A |
4881543 | Trembly et al. | Nov 1989 | A |
4887614 | Shirakami et al. | Dec 1989 | A |
4907589 | Cosman | Mar 1990 | A |
4920978 | Colvin | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4940064 | Desai | Jul 1990 | A |
4945912 | Langberg | Aug 1990 | A |
4947842 | Marchosky et al. | Aug 1990 | A |
4950267 | Ishihara et al. | Aug 1990 | A |
4962761 | Golden | Oct 1990 | A |
4963364 | Fox et al. | Oct 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4976680 | Hayman et al. | Dec 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4983159 | Rand | Jan 1991 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4989601 | Marchosky et al. | Feb 1991 | A |
5003991 | Takayama et al. | Apr 1991 | A |
5007908 | Rydell | Apr 1991 | A |
5009656 | Reimels | Apr 1991 | A |
5010897 | Leveen | Apr 1991 | A |
5011483 | Sleister | Apr 1991 | A |
5013312 | Parins et al. | May 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5016615 | Driller et al. | May 1991 | A |
5026959 | Ito et al. | Jun 1991 | A |
5047027 | Rydell | Sep 1991 | A |
5055100 | Olsen | Oct 1991 | A |
5057107 | Parins et al. | Oct 1991 | A |
5059199 | Okada et al. | Oct 1991 | A |
5067952 | Gudov et al. | Nov 1991 | A |
5071419 | Rydell et al. | Dec 1991 | A |
5078717 | Parins et al. | Jan 1992 | A |
5080660 | Buelna | Jan 1992 | A |
5083565 | Parins | Jan 1992 | A |
5084001 | Van't Hooft et al. | Jan 1992 | A |
5084045 | Helenowski | Jan 1992 | A |
5085659 | Rydell | Feb 1992 | A |
5099756 | Franconi et al. | Mar 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5115818 | Holleman et al. | May 1992 | A |
5119832 | Xavier | Jun 1992 | A |
5122137 | Lennox | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5128147 | Leveen et al. | Jul 1992 | A |
RE34086 | George | Oct 1992 | E |
5156151 | Imran | Oct 1992 | A |
5167626 | Casper et al. | Dec 1992 | A |
5169396 | Dowlatshahi et al. | Dec 1992 | A |
5170789 | Narayan et al. | Dec 1992 | A |
5170805 | Kensey et al. | Dec 1992 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5183455 | Hayman et al. | Feb 1993 | A |
5190517 | Zieve et al. | Mar 1993 | A |
5190539 | Fletcher et al. | Mar 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5190766 | Ishihara | Mar 1993 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5197964 | Parins | Mar 1993 | A |
5203353 | Easley et al. | Apr 1993 | A |
5203782 | Gudov et al. | Apr 1993 | A |
5205289 | Hardy et al. | Apr 1993 | A |
5207675 | Canady | May 1993 | A |
5215103 | Desai | Jun 1993 | A |
5217458 | Parins | Jun 1993 | A |
5222953 | Dowlatshahi | Jun 1993 | A |
5236410 | Granov et al. | Aug 1993 | A |
5236424 | Imran | Aug 1993 | A |
5246438 | Langberg | Sep 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5251645 | Fenn | Oct 1993 | A |
5252922 | Larson, III | Oct 1993 | A |
5257451 | Edwards et al. | Nov 1993 | A |
5258006 | Rydell et al. | Nov 1993 | A |
5259394 | Bens | Nov 1993 | A |
5259395 | Li | Nov 1993 | A |
5267994 | Gentelia et al. | Dec 1993 | A |
5273535 | Edwards et al. | Dec 1993 | A |
5275162 | Edwards et al. | Jan 1994 | A |
5277696 | Hagen | Jan 1994 | A |
5281213 | Milder et al. | Jan 1994 | A |
5281217 | Edwards et al. | Jan 1994 | A |
5281218 | Imran | Jan 1994 | A |
5282797 | Chess | Feb 1994 | A |
5286253 | Fucci | Feb 1994 | A |
5290286 | Parins | Mar 1994 | A |
5293869 | Edwards et al. | Mar 1994 | A |
5295955 | Rosen et al. | Mar 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5300099 | Rudie | Apr 1994 | A |
5304214 | DeFord et al. | Apr 1994 | A |
5309910 | Edwards et al. | May 1994 | A |
5313943 | Houser et al. | May 1994 | A |
5314466 | Stern et al. | May 1994 | A |
5322503 | Desai | Jun 1994 | A |
5328467 | Edwards et al. | Jul 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5334206 | Daikuzono | Aug 1994 | A |
5336222 | Durgin, Jr. et al. | Aug 1994 | A |
5342357 | Nardella | Aug 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5354296 | Turkel | Oct 1994 | A |
5363861 | Edwards et al. | Nov 1994 | A |
5365926 | Desai | Nov 1994 | A |
5366490 | Edwards et al. | Nov 1994 | A |
5368592 | Stern et al. | Nov 1994 | A |
5370675 | Edwards et al. | Dec 1994 | A |
5370678 | Edwards et al. | Dec 1994 | A |
5383876 | Nardella | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5385544 | Edwards et al. | Jan 1995 | A |
5397339 | Desai | Mar 1995 | A |
5398683 | Edwards et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405346 | Grundy et al. | Apr 1995 | A |
5409453 | Lundquist et al. | Apr 1995 | A |
5411025 | Webster, Jr. | May 1995 | A |
5417687 | Nardella | May 1995 | A |
5421819 | Edwards et al. | Jun 1995 | A |
5423807 | Milder | Jun 1995 | A |
5423808 | Edwards et al. | Jun 1995 | A |
5423811 | Imran et al. | Jun 1995 | A |
5433708 | Nichols et al. | Jul 1995 | A |
5435805 | Edwards et al. | Jul 1995 | A |
5437662 | Nardella | Aug 1995 | A |
5437664 | Cohen et al. | Aug 1995 | A |
5456662 | Edwards et al. | Oct 1995 | A |
5456682 | Edwards et al. | Oct 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5462521 | Brucker et al. | Oct 1995 | A |
5470308 | Edwards et al. | Nov 1995 | A |
5470309 | Edwards et al. | Nov 1995 | A |
5471982 | Edwards et al. | Dec 1995 | A |
5472441 | Edwards et al. | Dec 1995 | A |
5484400 | Edwards et al. | Jan 1996 | A |
5486161 | Lax et al. | Jan 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5507743 | Edwards et al. | Apr 1996 | A |
5509419 | Edwards et al. | Apr 1996 | A |
5514130 | Baker | May 1996 | A |
5514131 | Edwards | May 1996 | A |
5520684 | Imran | May 1996 | A |
5531676 | Edwards et al. | Jul 1996 | A |
5531677 | Lundquist et al. | Jul 1996 | A |
5536240 | Edwards et al. | Jul 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540655 | Edwards et al. | Jul 1996 | A |
5542915 | Edwards et al. | Aug 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5542928 | Evans et al. | Aug 1996 | A |
5545161 | Imran | Aug 1996 | A |
5545171 | Sharkey et al. | Aug 1996 | A |
5545193 | Fleischman et al. | Aug 1996 | A |
5546267 | Frederiksen et al. | Aug 1996 | A |
5548597 | Kayama et al. | Aug 1996 | A |
5549108 | Edwards et al. | Aug 1996 | A |
5549644 | Lundquist et al. | Aug 1996 | A |
5554110 | Edwards et al. | Sep 1996 | A |
5556377 | Rosen et al. | Sep 1996 | A |
5558672 | Edwards et al. | Sep 1996 | A |
5558673 | Edwards et al. | Sep 1996 | A |
5560358 | Arnold et al. | Oct 1996 | A |
5562703 | Desai | Oct 1996 | A |
5599345 | Edwards et al. | Feb 1997 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5620481 | Desai et al. | Apr 1997 | A |
5685839 | Edwards et al. | Nov 1997 | A |
5817092 | Behl | Oct 1998 | A |
5827276 | LeVeen et al. | Oct 1998 | A |
Number | Date | Country |
---|---|---|
2124684 | Nov 1972 | DE |
0 370 890 | May 1990 | EP |
0 462 302 | Dec 1991 | EP |
0 472 368 | Feb 1992 | EP |
0 502 268 | Sep 1992 | EP |
0 519 415 | Dec 1992 | EP |
0 608 609 | Aug 1994 | EP |
WO 9210142 | Jun 1992 | WO |
WO 9404220 | Mar 1994 | WO |
WO 9410925 | May 1994 | WO |
WO 9411059 | May 1994 | WO |
WO 9417856 | Aug 1994 | WO |
WO 9425110 | Nov 1994 | WO |
WO 9426178 | Nov 1994 | WO |
WO 9519142 | Jul 1995 | WO |
WO 9525471 | Sep 1995 | WO |
WO 9604860 | Feb 1996 | WO |
WO 9629946 | Oct 1996 | WO |
WO 9706739 | Feb 1997 | WO |
WO 9706855 | Feb 1997 | WO |
Number | Date | Country | |
---|---|---|---|
Parent | 08605323 | Feb 1996 | US |
Child | 08963239 | US | |
Parent | 08515379 | Aug 1995 | US |
Child | 08605323 | US | |
Parent | 08290031 | Aug 1994 | US |
Child | 08515379 | US | |
Parent | 08148439 | Nov 1993 | US |
Child | 08290031 | US |